Cleared Traditional

K011573 - HYALURONIDASE IN HTF MEDIUM

Also marketed or referenced as:
HYALURONIDASE IN EBSS MEDIUM

K011573 is an FDA 510(k) clearance for HYALURONIDASE IN HTF MEDIUM, manufactured by Conception Technologies. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K011573 · Conception Technologies · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2001
Decision
42d
Days
Class 2
Risk

K011573 is an FDA 510(k) clearance for the HYALURONIDASE IN HTF MEDIUM. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Conception Technologies (Irvine, US). The FDA issued a Cleared decision on July 2, 2001 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Conception Technologies devices

FDA 510(k) Submission Details - K011573

510(k) Number K011573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2001
Decision Date July 02, 2001
Days to Decision 42 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 160d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 197
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K011573.
EMBRYO BIOPSY MEDIUM
K021358 · Irvine Scientific Sales Co., Inc. · Jul 2002
EMBRYO FREEZE MEDIUM, EMBRYO THAW MEDIUM
K013518 · Irvine Scientific Sales Co., Inc. · Jan 2002
OIL FOR EMBRYO CULTURE
K011938 · Irvine Scientific Sales Co., Inc. · Jul 2001
COOK IVF CRYOPRESERVATION KIT AND THE COOK IVF THAW KIT
K011157 · Cook Urological, Inc. · May 2001
GLOBAL BY BLASTOCYST MEDIA
K010183 · Intl., Inc. · May 2001
BLASTASSIST SYSTEM
K003156 · Medicult A/S · Mar 2001